Patent ID: 7977104

Claim:
A method for quantitating the amount of an early pregnancy associated molecular isoform of human chorionic gonadotrophin (hCG) relative to the amount of intact, non-nicked hCG in a sample comprising: a) contacting a first portion of the sample with a first antibody which specifically binds to the early pregnancy associated molecular isoform of hCG, which isoform is recognized by the antibody produced by hybridoma cell line B152 (ATCC Designation No. HB-12467) under conditions permitting formation of a first complex between the first antibody and the early pregnancy associated molecular isoform of hCG so as to form the first complex, wherein the first antibody is labeled with a detectable marker which is a dye, radioactive isotope, enzyme, magnetic bead, or biotin; b) contacting a second portion of the sample with a second antibody produced by the hybridoma B109 having ATCC accession no. PTA 1624 which binds to intact, non-nicked hCG under conditions permitting formation of a second complex between the second antibody and the intact non-nicked hCG so as to form the second complex, wherein the second antibody is labeled with a detectable marker which is a dye, radioactive isotope, enzyme, magnetic bead, or biotin; and c) quantitating the amount of each of the first complex formed in step a) and the amount of the second complex formed in step b) and comparing the amounts so quantitated so as to thereby quantitate the amount of early pregnancy associated molecular isoform of hCG relative to the amount of intact, non-nicked hCG in the sample.